The centre emphasizes the importance of collaboration with various clinical and research groups at Oslo University Hospital (OUS), highlighting the proximity to the institute as a significant advantage.
Clinical Trials: The centre is actively involved in numerous ongoing investigator-initiated studies.
Goals:
Develop new therapeutic strategies for both early and metastatic breast cancer.
Contribute to more individualized and improved breast cancer treatments.
Enhance precision in selecting patients who do not require systemic adjuvant therapy.
Increase participation in international multicenter studies.
Anne Alexandra Østgaard, study nurse; Helle Kristine Skjerven, surgeon, Head of the Section for Breast and Endocrine Surgery; Randi Ruud Mathiesen, oncologist, Head of the Centre for Breast Cancer, Head of the Section for Breast Oncology; Bjørn Naume, oncologist, Head of the Clinical Research Group for Breast Cancer; Therese Sørlie, researcher, Head the Department for Cancer Genetics; Vigdis Sandviken Opperud, consultant; Linda Romundstad, radiologist, Department head at the Breast Diagnostic Centre; Eva Mari A. Harboe, cancer nurse, course coordinator; Jon Lømo, pathologist with specialist responsibility for breast. (click for larger image). Photo: Per Marius Didriksen
Ailte I, Chauhan SK, Prasmickaite L, Bassarova AV, Poissonnier A, Feenstra M, Nyakas M, Johannessen B, Ryder T, Hermann R, Frich L, Holth A, Inderberg EM, Jespersen H, Flørenes VA, Kyte JA, Mælandsmo GM, Egeland EV(2026) CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade Front Oncol, 16, 1815008 DOI 10.3389/fonc.2026.1815008, PubMed 42158424
Ayuda-Durán P, Hanes R, Rønneberg L, Alver TN, Øy GF, Hauge S, Andersen AN, Egeland EV, Juell S, Nakken S, Asenso TQ, Zucknick M, Syljuåsen RG, Mælandsmo GM, Hovig E, Enserink JM(2026) Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potential Commun Med (Lond), 6(1) DOI 10.1038/s43856-026-01583-w, PubMed 42062484
Azimzade Y, Haugen MH, Kristensen VN, Frigessi A, Köhn-Luque A(2026) Explainable machine learning-guided integrated multiomics analysis reveals macrophage-driven immune suppression in breast cancer Nat Commun(in press) DOI 10.1038/s41467-026-73617-9, PubMed 42185288